Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

NOTARBARTOLO DI VILLAROSA, Monica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.808
EU - Europa 2.555
AS - Asia 1.040
SA - Sud America 248
AF - Africa 47
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.704
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.776
IT - Italia 992
FI - Finlandia 424
CN - Cina 399
SG - Singapore 397
UA - Ucraina 342
BR - Brasile 223
DE - Germania 208
IE - Irlanda 160
GB - Regno Unito 112
SE - Svezia 69
TR - Turchia 64
RU - Federazione Russa 62
IN - India 56
FR - Francia 50
BE - Belgio 24
NL - Olanda 23
RO - Romania 22
HK - Hong Kong 20
BG - Bulgaria 18
CI - Costa d'Avorio 17
KR - Corea 15
AT - Austria 13
MX - Messico 12
IR - Iran 11
EG - Egitto 9
CA - Canada 8
MY - Malesia 8
VN - Vietnam 8
CH - Svizzera 7
CZ - Repubblica Ceca 7
IQ - Iraq 7
SY - Repubblica araba siriana 7
MA - Marocco 6
TN - Tunisia 6
UZ - Uzbekistan 6
CL - Cile 5
ES - Italia 5
JP - Giappone 5
LB - Libano 5
PK - Pakistan 5
AR - Argentina 4
AU - Australia 4
BD - Bangladesh 4
KZ - Kazakistan 4
UY - Uruguay 4
CO - Colombia 3
DZ - Algeria 3
HN - Honduras 3
JM - Giamaica 3
MT - Malta 3
PH - Filippine 3
PL - Polonia 3
PY - Paraguay 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
EC - Ecuador 2
GR - Grecia 2
GT - Guatemala 2
LT - Lituania 2
LY - Libia 2
NO - Norvegia 2
PA - Panama 2
PS - Palestinian Territory 2
SI - Slovenia 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
DO - Repubblica Dominicana 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
GH - Ghana 1
IL - Israele 1
JO - Giordania 1
KG - Kirghizistan 1
LK - Sri Lanka 1
NI - Nicaragua 1
OM - Oman 1
RS - Serbia 1
SA - Arabia Saudita 1
SN - Senegal 1
TH - Thailandia 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
ZA - Sudafrica 1
Totale 8.704
Salva come PNG Salva come JPEG
Città #
Fairfield 633
Ashburn 401
Chandler 379
Houston 376
Woodbridge 364
Palermo 313
Wilmington 270
Ann Arbor 269
Singapore 252
Seattle 229
Cambridge 199
Jacksonville 187
Dublin 153
Medford 128
Des Moines 123
Nanjing 84
Princeton 79
Boardman 69
Altamura 62
Tulsa 52
Lawrence 50
Santa Clara 49
Beijing 47
New York 47
San Diego 46
Dearborn 43
The Dalles 36
Helsinki 31
Milan 30
Shenyang 29
Hebei 27
Izmir 27
Venice 27
Nanchang 25
Changsha 23
Bremen 22
Brussels 22
Ludwigshafen am Rhein 22
London 21
Rome 21
Los Angeles 20
Abidjan 17
Sofia 17
Falls Church 16
Ningbo 16
Nuremberg 16
San Paolo di Civitate 16
Hong Kong 15
Messina 15
Council Bluffs 14
Seongnam 14
Catania 13
São Paulo 13
Verona 13
Auburn Hills 11
Jiaxing 11
Jinan 11
Zhengzhou 11
Kumar 10
Saint Petersburg 10
San Mateo 10
Columbus 9
Guangzhou 9
Salerno 9
Belo Horizonte 8
Brescia 8
Haikou 8
Lappeenranta 8
Pune 8
Rio de Janeiro 8
Tianjin 8
Capaci 7
Durham 7
Hangzhou 7
Naples 7
Sanayi 7
Shanghai 7
Atlanta 6
Brasília 6
Campinas 6
Frankfurt am Main 6
Istanbul 6
Kilburn 6
Munich 6
New Delhi 6
Norwalk 6
Syracuse 6
Taizhou 6
Bengaluru 5
Lahore 5
Lanzhou 5
Napoli 5
Nha Trang 5
Orange 5
Redwood City 5
San Giuliano Milanese 5
Tashkent 5
Vienna 5
Bologna 4
Dallas 4
Totale 5.805
Salva come PNG Salva come JPEG
Nome #
Targeting Multiple Myeloma with natural polyphenols 215
ANTITUMOR EFFECTS OF CURCUMIN, ALONE OR IN COMBINATION WITH CISPLATIN OR DOXORUBICIN, ON HUMAN HEPATIC CANCER CELLS. ANALYSIS OF THEIR POSSIBLE RELATIONSHIP TO CHANGES IN NF-KB ACTIVATION LEVELS AND IAP GENE EXPRESSION 202
Chemical Composition, In Vitro Antitumor and Pro-Oxidant Activities of Glandora rosmarinifolia (Boraginaceae) Essential Oil 193
Yin Yang 1 and Raf-1 Kinase Inhibitory Protein Status in Hepatocellular Carcinoma: Future Perspectives 187
Antitumor mechanism of the essential oils from two succulent plants in multidrug resistance leukemia cell 186
Induction of Apoptosis and Chemosensitization by the Histone Deacetylase Inhibitor Trichostatin in Hepatocellular Carcinoma Cells: Molecular Analysis and RKIP Levels 179
Essential oil of Cyphostemma juttae (Vitaceae): chemical composition and antitumor mechanism in triple negative breast cancer cells 179
Curcumin as a possible lead compound against hormone-independent, multidrug-resistant breast cancer 173
Frequent Alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein Ratio in Hepatocellular Carcinoma 170
Antitumor effects of curcumin and structurally beta-diketone modified analogs on multidrug resistant cancer cells 167
Expression of the IAPs in multidrug resistant tumor cells 163
Expression of WISPs and of their novel alternative variants in human hepatocellular carcinoma cells 162
Analysis of Possible Mechanisms Accounting for Raf-1 Kinase Inhibitor Protein Downregulation in Hepatocellular Carcinoma 157
Epigenetic changes and nuclear factor-κB activation, but not microRNA-224, downregulate Raf-1 kinase inhibitor protein in triple‑negative breast cancer SUM 159 cells 153
The antitumor activities of curcumin and its isoxazole analogue are not affected by multiple gene expression changes in an MDR model of the MCF-7 brest cancer cell line: Analysis of the possible molecular basis. 147
Unusual high dose of tacrolimus in liver transplant patient, a case report. 138
Mechanisms of Raf-1 Kinase Inhibitor Protein Dysregulation in Triple-Negative Breast Cancers and Identification of Possible Novel Therapeutic Approaches for These Tumors 138
Influence of CYP3A5 and ABCB1 gene polymorphisms and other factors on tacrolimus dosing in Caucasian liver and kidney transplant patients. 137
Cytotoxicity of oleanolic and ursolic acid derivatives toward hepatocellular carcinoma and evaluation of NF-κB involvement 137
Essential Oil Composition of Alluaudia procera and in Vitro Biological Activity on Two Drug-Resistant Models 137
Synthesis of Curcumin Derivatives and Analysis of Their Antitumor Effects in Triple Negative Breast Cancer (TNBC) Cell Lines 133
NF-kB Is a Potential Molecular Drug Target in Triple-Negative Breast Cancers 130
Induction of apoptosis and inhibition of cell growth in human hepatocellular carcinoma cells by COX-2 inhibitors 129
Effetti della curcumina e di suoi analoghi modificati al frammento beta-dichetone in cellule tumorali multifarmacoresistenti. 125
Pro-oxidant and antitumor effects of curcumin and N-ethylmaleimide in the HA22T/VGH model Overt hepatocellular carcinoma. 125
"Antitumor effects of the novel NF-kB inhibitor dehydroxymethylepoxyquinomicin (DHMEQ) on human hepatic cancer cells: analysis of synergy with cisplatin and of possible correlation with inhibition of pro-survival genes and IL-6 production”. 124
Lack of nucleophilic addition in the isoxazole and pyrazole diketone modified analogs of curcumin; implications for their antitumor and chemosensitizing activities. 121
Frequent alteration of the Yin Yang 1/Raf-1 Kinase Inhibitory Protein ratio in hepatocellular carcinoma 121
Pharmacogenetic considerations for optimizing tacrolimus dosing in liver and kidney transplant patients 118
Can NF-κB Be Considered a Valid Drug Target in Neoplastic Diseases? Our Point of View 117
Altered Yin Yang 1/RAF-1 kinase inhibitory protein ratio as a possible molecular marker and therapeutic target in hepatocellular carcinoma 112
Prostaglandin E2 receptors and COX enzymes in human hepatocellular carcinoma: role in the regulation of cell growth 110
USE OF HERBAL REMEDIES AMONG CANCER AND TRANSPLANT PATIENTS IN THE TOWN OF PALERMO, SICILY 110
Potential Therapeutic Applications of MDA-9/Syntenin-NF-κB-RKIP Loop in Human Liver Carcinoma 110
Abilities of β-Estradiol to interact with chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals and alter the proliferation of pancreatic cancer cells 109
In Vitro Modulation of P-Glycoprotein Activity by Euphorbia intisy Essential Oil on Acute Myeloid Leukemia Cell Line HL-60R 106
Resistance to gemcitabine in a lymphoma cell line resistant to Fas-mediated apoptosis 105
Meccanismi antitumorali degli oli essenziali estratti da piante succulente in un modello di leucemia mielocitica acuta multifarmacoresistente 105
Phytol and heptacosane: the two major components of Euphorbia intisy essential oil with biological activities in drug resistant leukemia cell. 105
Induction of apoptosis by the adenosine derivative IB-MECA in parental or multidrug-resistant HL-60 leukemia cells: possibile relationship to the effects on inhibitor of apoptosis protein levels 104
Rash and multiorgan dysfunction following lamotrigine: could genetic be involved? 104
Induction of apoptosis by the proteasome inhibitor MG132 in human HCC cells: Possible correlation with specific caspase-dependent cleavage of β-catenin and inhibition of β-catenin-mediated transactivation 103
The selective cyclooxygenase-1 inhibitor SC-560 suppresses cell proliferation and induces apoptosis in human hepatocellular carcinoma cells 103
Alteration of signaling pathways in hepatocellular carcinoma: identification of new pharmacological targets and possible prognosis markers. 102
The NF-kB inhibitors curcumin and DHMEQ exert antitumor synergy with cisplatin in hepatic cancer cells. Analysis of relationship to IL-6 production. 101
The effect of CYP3A5 and ABCB1 single nucleotide polymorphisms on tacrolimus dose requirements in Caucasian liver transplant patients 100
Expression of HIP/PAP mRNA in Human Hepatoma Cell Lines 90
Bioactive triterpenes of protium heptaphyllum gum resin extract display cholesterol-lowering potential 90
Expression of IAPs (Inhibitory of Apoptosis Proteins) and of their alternative splice variants in hepatocellular carcinoma tissues and cells 89
Nanocarrier based on halloysite and fluorescent probe for intracellular delivery of peptide nucleic acids 89
Use of herbal products among cancer and transplanted patients in the town of Palermo,Sicily. 88
Plant polyphenols as possible lead compound against hormone-independent multidrug resistant breast cancer. 87
Antitumor effects of curcumin in human hepatic cancer cells: Analysis of their relationship to inhibition of NF-kB and pro-survival gene expression. 86
Antitumor effects of curcumin, alone or in combination with cisplatin, on hepatic cancer cells. Analysis of their relationship to IL-6 production 85
Antitumor effects of the NF-kB inhibitors curcumin and DHMEQ, alone or combined with cisplatin, on hepatic cancer cells. analysis of their relationship to IL-6 production. 83
Prodrug based on halloysite delivery systems to improve the antitumor ability of methotrexate in leukemia cell lines 78
ELABORATION OF CURCUMIN INTO DIKETONE MODIFIED ANALOGUES DEVOID OF NUCLEOPHILIC ADDITION CAPABILITY; IMPLICATIONS FOR THEIR ANTITUMOR AND CHEMOSENSITIZING ACTIVITIES 77
Analysis of UGT1A1*28 and DPYD*2A polymorphisms in Sicilians patients with metastatic colorectal cancer treated with Irinotecan and 5-fluorouracil. 76
Raf-1 Kinase Inhibitor Protein down-regulation in hepatocellular carcinoma: investigation of possible mechanisms 74
Effetti della curcumina e del suo derivato isossazolico in modelli di neoplasia multifarmacoresistente 72
Phytol and Heptacosane Are Possible Tools to Overcome Multidrug Resistance in an In Vitro Model of Acute Myeloid Leukemia 71
Analysis of pharmacologic approaches able to restore RKIP function in hepatocellular carcinoma 70
Antitumor effects of curcumin and of its combination with cisplatin or doxorubicin on human hepatic cancer cells: possible relationship to NF-kB activation and IAP gene expression. 67
DISTRIBUTION OF CYP3A5 AND MDR-1 SINGLE NUCLEOTIDE POLYMORPHISMS IN CAUCASIAN LIVER TRANSPLANT PATIENTS 67
THE EFFECT OF CYP3A5 AND ABCB1 SINGLE NUCLEOTIDE POLYMORPHISMS ON TACROLIMUS DOSE REQUIREMENTS IN CAUCASIAN LIVER TRANSPLANT PATIENTS 67
null 67
Effects of curcumin and related analogues on tumor cell lines expressing multiple mechanisms of drug resistance 66
Citrus wastewater as a source of value‐added products: Quali‐quantitative analysis and in vitro screening on breast cancer cell lines 65
Restoration of Raf-1 Kinase Inhibitor Protein levels as a possible therapeutic approach in hepatocellular carcinoma. 65
Possible mechanisms of Raf-1 Kinase Inhibitor Protein down-regulation in hepatocellular carcinoma 65
Ihnibitor of Apoptosis Proteins (IAPs) as a new possible therapeutic targets in hepatocellular cancer. 64
Synthesis, In Vitro and In Silico Analysis of New Oleanolic Acid and Lupeol Derivatives against Leukemia Cell Lines: Involvement of the NF-κB Pathway 62
New trends in overcoming drug resistance in hepatocellular carcinoma. Looking for pharmacological inhibition of Inhibitory of Apoptosis Proteins (IAPs) by curcumin. 60
Effects of the dietary polyphenols resveratrol and curcumin on the prevention and treatment of cancer. 58
Prostaglandin E2 receptors and COX enxymes in human hepatocellular carcinoma: role in the regulation of cell growth 58
Cancer therapy and treatments during COVID-19 era 57
The selective COX-1 inhibitor SC-560 inhibits cell growth and induces apoptosis in human hepatocellular carcinoma cells 56
NF-κB is a potential pharmacological target in triple negative breast cancers. 54
Recovery of Bioactive Compounds from Marine Organisms: Focus on the Future Perspectives for Pharmacological, Biomedical and Regenerative Medicine Applications of Marine Collagen 53
Natural Inhibitors of P-glycoprotein in AcuteMyeloid Leukemia 53
Novel insights on [1,2]oxazolo[5,4‐e]isoindoles on multidrug resistant acute myeloid leukemia cell line 52
Alteration of the YY1/RKIP ratio is a frequent event in hepatocellular carcinoma 48
Exploring the cellular uptake of hectorite clay mineral and its drug carrier capabilities 47
Patterns of Innate or Acquired Resistance to Anticancer Drugs: Our Experience to Overcome It 46
Antitumor Effect of Glandora rosmarinifolia (Boraginaceae) Essential Oil through Inhibition of the Activity of the Topo II Enzyme in Acute Myeloid Leukemia 46
MDA-9/Syntenin-NF-κB-RKIP loop in triple negative breast cancers (TNBC) and human liver carcinoma 43
Supramolecular Association of Halochromic Switches and Halloysite Nanotubes in Fluorescent Nanoprobes for Tumor Detection 36
Antimigratory effects of a new NF-κB inhibitor, (S)-b-salicyloylamino-a-exo-methylene-ƴ-butyrolactone, in 2D and 3D breast cancer models 32
Comparison of Synthetic Pathways for Obtaining Fluorescent Nanomaterials Based on Halloysite and Carbon Dots for Potential Biological Sensing 31
Carrier capability of halloysite nanotubes for the intracellular delivery of antisense PNA targeting mRNA of neuroglobin gene 29
PLLA Porous Scaffold as a 3D Breast Cancer Model to Investigate Drug Resistance 27
Vesicle-Transported Multidrug Resistance as a Possible Therapeutic Target of Natural Compounds 20
Design of innovative and low-cost dopamine-biotin conjugate sensor for the efficient detection of protein and cancer cells 16
Epigenetic and Cellular Reprogramming of Doxorubicin-Resistant MCF-7 Cells Treated with Curcumin 14
Totale 9.148
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.408
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.408
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020303 0 0 0 0 0 0 0 0 0 102 126 75
2020/20211.000 40 89 43 98 88 53 81 76 130 83 129 90
2021/20221.070 49 222 30 21 44 28 74 40 98 166 90 208
2022/20231.271 134 214 26 145 158 203 101 80 125 10 60 15
2023/2024712 39 87 53 31 44 131 53 49 14 40 43 128
2024/20251.449 43 158 113 200 125 99 202 141 177 191 0 0
Totale 9.148